CLLS
Cellectis SA
NASDAQ: CLLS · HEALTHCARE · BIOTECHNOLOGY
$3.90
+4.56% today
Updated 2026-04-30
Market cap
$391.30M
P/E ratio
—
P/S ratio
4.92x
EPS (TTM)
$-0.67
Dividend yield
—
52W range
$1 – $5
Volume
0.0M
Cellectis SA (CLLS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+33.0%
Last 4 quarters
Revenue YoY growth
-18.3%
Most recent quarter
EPS YoY growth
-50.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+13.4%
2025-11-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $-0.24 | +18.6% | $3.82 | $3.33 | -12.8% |
| 2025-11-07 | $0.01 | +104.3% | $3.13 | $3.55 | +13.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.29 | $-0.24 | +18.6% | $10.40M | -18.3% |
| 2025-09-30 | $-0.23 | $0.01 | +104.3% | $35.17M | +117.1% |
| 2025-06-30 | $-0.20 | $-0.24 | -20.0% | $16.73M | +107.5% |
| 2025-03-31 | $-0.24 | $-0.17 | +29.2% | $10.65M | +135.3% |
| 2024-12-31 | $-0.09 | $-0.16 | -77.8% | $12.72M | +4393.6% |
| 2024-09-30 | $-0.21 | $-0.23 | -9.5% | $16.20M | +10351.6% |
| 2024-06-30 | $-0.30 | $-0.28 | +6.7% | $8.06M | +4428.7% |
| 2024-03-31 | $-0.22 | $-0.70 | -218.2% | $4.53M | +3157.6% |
| 2023-12-31 | $-0.22 | $-0.70 | -218.2% | $283000.00 | — |
| 2023-09-30 | $-0.42 | $-0.31 | +26.2% | $155000.00 | — |
| 2023-06-30 | $-0.45 | $-0.19 | +57.8% | $178000.00 | — |
| 2023-03-31 | $-0.48 | $-0.58 | -20.8% | $139000.00 | — |
Frequently asked questions
Has Cellectis SA beaten earnings estimates?
Cellectis SA has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +33.0% over the last 4 quarters.
How does CLLS stock react to earnings?
CLLS stock has moved an average of +0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Cellectis SA's revenue growth rate?
Cellectis SA reported year-over-year revenue growth of -18.3% in its most recent quarter, with EPS growing -50.0% year-over-year.